ReachMD

ReachMD CME

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Určitě navštivte web podcastu a podpořte jeho tvůrce: reachmd.com

Autor

ReachMD

Kategorie

Science

Web podcastu

reachmd.com

Nejnovější epizoda

24. srp 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Stáhnout z Google Play Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD 31.10.2025

CME credits: 0.25 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/case-based-approach-optimizing-cardio-kidney-metabolic-outcomes-in-individuals-with-t2d-ckd/29906/ This case-based program explores the missed opportunities in CKD detection and treatment in a patient with type 2 diabetes. Drs. Agarwal and Cos emphasize the role of primary care physicians in annual...

Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia 30.10.2025

CME credits: 0.25 Valid until: 30-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/are-all-vmat2s-the-same-data-driven-treatment-decisions-for-tardive-dyskinesia/36174/ Tardive Dyskinesia (TD) is an involuntary movement disorder that can develop as a side effect of taking antipsychotic and other medications. Currently there are 2 FDA approved VMAT2 inhibitors for treating TD. Join...

Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology 29.10.2025

CME credits: 0.50 Valid until: 29-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/mechanism-driven-gmg-therapy-fcrn-antagonists-and-the-rise-of-precision-neurology/36277/ This Clinical Countdown addresses key challenges in diagnosing and managing generalized myasthenia gravis (gMG), with a focus on FcRn antagonists. Drs. Edmundson and Goyal review diagnostic challenges in gMG, al...

The Patient-Clinician Connection in Managing CKD-aP 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-patient-clinician-connection-in-managing-ckd-ap/36302/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology,...

Improving Sleep and Mental Health in Patients with CKD-aP 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/improving-sleep-and-mental-health-in-patients-with-ckd-ap/36301/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etio...

Kappa-Opioid Settings: Real-World Evidence Insights 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, a...

Is CKD-aP Hiding in Your Dialysis Center? 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/is-ckd-ap-hiding-in-your-dialysis-center/36299/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidi...

Elevating CKD-aP Care: New Frontier 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/elevating-ckd-ap-care-new-frontier/36298/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensio...

CKD-aP Treatment Tool Kit 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/ckd-ap-treatment-tool-kit/36297/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impac...

CKD-aP or Something Else? Decoding the Diagnosis 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/ckd-ap-or-something-else-decoding-the-diagnosis/36296/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and...

Quantifying CKD-aP: Tools for Better Care 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/quantifying-ckd-ap-tools-for-better-care/36295/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidi...

CKD-aP: Beyond the Surface 24.10.2025

CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/ckd-ap-beyond-the-surface/36294/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impac...

Advances in the Treatment of Hepatic Encephalopathy 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-an-ominous-sign/39666/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discuss clinic...

Hepatic Encephalopathy: Unmet Therapeutic Needs 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-unmet-therapeutic-needs/39665/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discus...

Treatment of Overt Hepatic Encephalopathy 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/treatment-of-overt-hepatic-encephalopathy/39664/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discuss cli...

Hepatic Encephalopathy: What's Sarcopenia Got to Do With It? 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-whats-sarcopenia-got-to-do-with-it/39663/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven F...

Diagnosing Minimal Hepatic Encephalopathy: There's an App for That? 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/diagnosing-minimal-hepatic-encephalopathy-theres-an-app-for-that/39662/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and S...

You Can’t Diagnose MHE Unless You Diagnose Cirrhosis 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/you-cant-diagnose-mhe-unless-you-diagnose-cirrhosis/39661/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm d...

Hepatic Encephalopathy: Tipping the Balance 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-tipping-the-balance/39660/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discuss cl...

The Clinical Spectrum of Hepatic Encephalopathy 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/the-clinical-spectrum-of-hepatic-encephalopathy/39304/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discu...

Hepatic Encephalopathy: An Ominous Sign 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-an-ominous-sign/39278/ This series of brief episodes addresses how primary care providers can recognize early and often subtle signs of hepatic encephalopathy to support timely diagnosis and intervention. Drs. Robert Brown and Steven Flamm discuss clinic...

Not Just a Headache: Migraine Across Women’s Lifespan 23.10.2025

CME credits: 1.00 Valid until: 23-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/not-just-a-headache-migraine-across-womens-lifespan/36591/ This session from WHAV 2025 explores the complex interplay between hormonal changes and migraine pathophysiology in women, from menarche through menopause. Faculty review diagnostic frameworks, including ICHD-3 criteria, and emphasize menstr...

ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years 22.10.2025

CME credits: 1.00 Valid until: 22-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/endovoice-live-endometriosisa-chronic-burden-of-reproductive-years/37176/ This dynamic symposium will guide clinicians through a modern, patient-centered approach to endometriosis care. Faculty will explore how early diagnosis can improve physical and psychosocial outcomes, examine tools to advance...

Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden 22.10.2025

CME credits: 1.00 Valid until: 22-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/primary-biliary-cholangitis-shining-light-on-an-invisible-female-health-burden/36709/ This WHAV 2025 session examines primary biliary cholangitis (PBC), a chronic autoimmune liver disease that predominantly affects women and often goes unrecognized. Tailored for clinicians who play a key role in ide...

Global Perspectives on Data in Type 2 Diabetes — Congress-to-Clinic Insights 22.10.2025

CME credits: 1.00 Valid until: 21-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/global-perspectives-on-data-in-type-2-diabetes-congress-to-clinic-insights/36231/ On-demand webcast with expert faculty presentation highlighting key studies in diabetes from the 2025 American Diabetes Association and European Association for the Study of Diabetes annual meetings. =

Poslouchej podcast ReachMD CME v Replaio

Rádio a podcasty v jedné aplikaci - zdarma a bez registrace. Nainstaluj si ji ještě dnes a nepropásni premiéru

Stáhnout z Google Play

Replaio není vydavatelem podcastů; názvy pořadů, obálky a audio patří jejich autorům a šíří se přes veřejné RSS kanály